Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07769437 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Non-nutritive Sweeteners in Inflammatory Bowel Disease

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 25 words
    • Secondary endpoints: details revised at 2 of 4 entries
    • Study description revised
    • Collaborators: details revised at 1 of 1 entry
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will focus on the commonly used non-nutritive sweetener (NNS) sucralose (2 sachets/day resulting in daily dose: sucralose 2.5mg/kg) and its role in changing the gut microbiota in humans with IBD, compared to healthy non-IBD individuals. The investigators will focus on studying IBD patients affected with CD as a proof of principle that could be tested later in other IBD subtype (ulcerative colitis or others specific surgical conditions).
Trial Details
NCT Number NCT07769437
Lead Sponsor University Hospitals Cleveland Medical Center
Collaborators: Crohn's and Colitis Foundation
Conditions
(from sponsor)		 Inflamatory Bowel Disease, Crohn Disease (CD)
Related terms Crohn Disease, Inflammatory Bowel Diseases
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov